Novena Global Lifecare defers listing after MOU with Yozma BioScience
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
HOMEGROWN healthcare chain Novena Global Lifecare has held off its IPO plans following a recent fund injection. Instead, it is looking to list its subsidiary Novena Life Sciences probably sooner than itself.
Novena Global Lifecare had in July 2017 announced year plans to list on the Hong Kong market, but was convinced otherwise after a round of private investing and has decided to defer the listing.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Ministry of Home Affairs Permanent Secretary Pang Kin Keong to retire
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
